Immunolipoplexes: an efficient, nonviral alternative for transfection of human dendritic cells with potential for clinical vaccination.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 15851017)

Published in Mol Ther on May 01, 2005

Authors

Peng H Tan1, Sven C Beutelspacher, Yao-He Wang, Myra O McClure, Mary A Ritter, Giovanna Lombardi, Andrew J T George

Author Affiliations

1: Department of Immunology, Division of Medicine, Faculty of Medicine, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 ONN, UK.

Articles by these authors

Failure to detect the novel retrovirus XMRV in chronic fatigue syndrome. PLoS One (2010) 4.66

Mouse DNA contamination in human tissue tested for XMRV. Retrovirology (2010) 2.65

Identification of gammaretroviruses constitutively released from cell lines used for human immunodeficiency virus research. J Virol (2008) 2.27

The safety and side effects of monoclonal antibodies. Nat Rev Drug Discov (2010) 2.23

Antigen-specific T cell suppression by human CD4+CD25+ regulatory T cells. Eur J Immunol (2002) 2.18

Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretroviral defense factors. J Virol (2005) 1.84

Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle. Transplantation (2007) 1.83

Resident CD141 (BDCA3)+ dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation. J Exp Med (2012) 1.81

CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS). Blood (2007) 1.80

Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men. Gut (2010) 1.77

Inhibition of human immunodeficiency virus type 1 replication in primary macrophages by using Tat- or CCR5-specific small interfering RNAs expressed from a lentivirus vector. J Virol (2003) 1.73

Analysis of gene expression in cancer cell lines identifies candidate markers for pancreatic tumorigenesis and metastasis. Int J Cancer (2004) 1.68

Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice. J Clin Invest (2008) 1.68

Induction of allopeptide-specific human CD4+CD25+ regulatory T cells ex vivo. Blood (2003) 1.63

Human regulatory T cells with alloantigen specificity are more potent inhibitors of alloimmune skin graft damage than polyclonal regulatory T cells. Sci Transl Med (2011) 1.56

DNA extraction columns contaminated with murine sequences. PLoS One (2011) 1.55

Ubiquitin-dependent virus particle budding without viral protein ubiquitination. Proc Natl Acad Sci U S A (2007) 1.51

Goodpasture's disease in the absence of circulating anti-glomerular basement membrane antibodies as detected by standard techniques. Am J Kidney Dis (2002) 1.42

Comparative response of African HIV-1-infected individuals to highly active antiretroviral therapy. AIDS (2002) 1.33

IL-17-producing CD4(+) T cells, pro-inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndrome. Br J Haematol (2009) 1.30

CD205 (DEC-205): a recognition receptor for apoptotic and necrotic self. Mol Immunol (2009) 1.29

Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV. AIDS (2009) 1.28

Type I interferons and the innate immune response--more than just antiviral cytokines. Mol Immunol (2005) 1.26

B-cell depletion reveals a role for antibodies in the control of chronic HIV-1 infection. Nat Commun (2010) 1.26

Modulation of human dendritic-cell function following transduction with viral vectors: implications for gene therapy. Blood (2005) 1.24

Function of indoleamine 2,3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression. Eur J Immunol (2006) 1.24

Chronic exposure to Helicobacter pylori impairs dendritic cell function and inhibits Th1 development. Infect Immun (2006) 1.21

A one-step SYBR Green I-based product-enhanced reverse transcriptase assay for the quantitation of retroviruses in cell culture supernatants. J Virol Methods (2008) 1.21

The maintenance of human CD4+ CD25+ regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro. Int Immunol (2007) 1.20

Detection of vascular expression of E-selectin in vivo with MR imaging. Radiology (2006) 1.18

A new human antitumor immunoreagent specific for ErbB2. Clin Cancer Res (2002) 1.18

High prevalence of macrolide resistant Treponema pallidum strains in a London centre. Sex Transm Infect (2011) 1.18

Inhibition of NF-kappa B and oxidative pathways in human dendritic cells by antioxidative vitamins generates regulatory T cells. J Immunol (2005) 1.15

Helicobacter pylori stimulates dendritic cells to induce interleukin-17 expression from CD4+ T lymphocytes. Infect Immun (2009) 1.15

Regulatory T cells as therapeutic cells. Curr Opin Organ Transplant (2008) 1.14

Inflammatory cytokines induce apoptosis of corneal endothelium through nitric oxide. Invest Ophthalmol Vis Sci (2004) 1.13

Differential effects of rapamycin and retinoic acid on expansion, stability and suppressive qualities of human CD4(+)CD25(+)FOXP3(+) T regulatory cell subpopulations. Haematologica (2012) 1.12

The relative efficiency of acquisition of MHC:peptide complexes and cross-presentation depends on dendritic cell type. J Immunol (2008) 1.11

A rapid diagnostic test for human regulatory T-cell function to enable regulatory T-cell therapy. Blood (2012) 1.10

Identification of domains in gag important for prototypic foamy virus egress. J Virol (2005) 1.09

Detection of HIV-1 antiretroviral resistance from patients with persistently low but detectable viraemia. J Virol Methods (2004) 1.09

CD161 expression characterizes a subpopulation of human regulatory T cells that produces IL-17 in a STAT3-dependent manner. Eur J Immunol (2013) 1.07

Pgp3 antibody enzyme-linked immunosorbent assay, a sensitive and specific assay for seroepidemiological analysis of Chlamydia trachomatis infection. Clin Vaccine Immunol (2009) 1.05

Qualitatively distinct patterns of cytokines are released by human dendritic cells in response to different pathogens. Immunology (2005) 1.04

Xenogeneic graft-versus-host-disease in NOD-scid IL-2Rγnull mice display a T-effector memory phenotype. PLoS One (2012) 1.04

The T helper 17-regulatory T cell axis in transplant rejection and tolerance. Curr Opin Organ Transplant (2009) 1.04

Gene delivery by dendrimers operates via a cholesterol dependent pathway. Nucleic Acids Res (2004) 1.03

The importance of the indirect pathway of allorecognition in clinical transplantation. Curr Opin Immunol (2008) 1.03

Pathways of major histocompatibility complex allorecognition. Curr Opin Organ Transplant (2008) 1.02

IFN-alpha subtypes differentially affect human T cell motility. J Immunol (2004) 1.02

Modulation of dendritic cell phenotype and function in an in vitro model of the intestinal epithelium. Eur J Immunol (2006) 1.02

Dendritic cells as a tool to induce transplantation tolerance: obstacles and opportunities. Transplantation (2011) 1.02

Programmed death ligand-1 over-expression correlates with malignancy and contributes to immune regulation in ovarian cancer. Cancer Immunol Immunother (2013) 1.01

CD73 expression on extracellular vesicles derived from CD4+ CD25+ Foxp3+ T cells contributes to their regulatory function. Eur J Immunol (2013) 1.01

Activated CD1d-restricted natural killer T cells secrete IL-2: innate help for CD4+CD25+ regulatory T cells? Eur J Immunol (2005) 1.01

Identification of synovium-specific homing peptides by in vivo phage display selection. Arthritis Rheum (2002) 1.01

Comparison of regulatory T cells in hemodialysis patients and healthy controls: implications for cell therapy in transplantation. Clin J Am Soc Nephrol (2013) 1.01

Investigation into the presence of and serological response to XMRV in CFS patients. PLoS One (2011) 1.01

Restriction of V3 region sequence divergence in the HIV-1 envelope gene during antiretroviral treatment in a cohort of recent seroconverters. Retrovirology (2013) 1.00

Oscillations in the immune system. Immunol Rev (2007) 1.00

Hemopoietic cell expression of the chemokine decoy receptor D6 is dynamic and regulated by GATA1. J Immunol (2008) 0.99

T-cell alloimmunity and chronic allograft dysfunction. Kidney Int Suppl (2010) 0.99

Relative roles of Th1 and Th17 effector cells in allograft rejection. Curr Opin Organ Transplant (2009) 0.99

Reconstruction of cell population dynamics using CFSE. BMC Bioinformatics (2007) 0.99

Modulation of costimulation by CD28 and CD154 alters the kinetics and cellular characteristics of corneal allograft rejection. Invest Ophthalmol Vis Sci (2003) 0.99

Stable inhibition of hepatitis B virus proteins by small interfering RNA expressed from viral vectors. J Gene Med (2005) 0.98

T-lymphocyte invasiveness: control by voltage-gated Na+ channel activity. FEBS Lett (2004) 0.98

High resolution spectral domain optical coherence tomography (SD-OCT) in multiple sclerosis: the first follow up study over two years. PLoS One (2011) 0.98

Feedback control of T-cell receptor activation. Proc Biol Sci (2004) 0.98

Thymic versus induced regulatory T cells - who regulates the regulators? Front Immunol (2013) 0.98

Cell-cycle dependence of foamy virus vectors. J Gen Virol (2004) 0.98

Nef decreases HIV-1 sensitivity to neutralizing antibodies that target the membrane-proximal external region of TMgp41. PLoS Pathog (2011) 0.98

Hemopoietic cell expression of the chemokine decoy receptor D6 is dynamic and regulated by GATA1. J Immunol (2008) 0.97

Functional modulation of human monocytes derived DCs by anaphylatoxins C3a and C5a. Immunobiology (2011) 0.97

Effect of time since exposure to Chlamydia trachomatis on chlamydia antibody detection in women: a cross-sectional study. Sex Transm Infect (2013) 0.97

Altered proximal T cell receptor (TCR) signaling in human CD4+CD25+ regulatory T cells. J Leukoc Biol (2006) 0.96

Expression of complement components, receptors and regulators by human dendritic cells. Mol Immunol (2011) 0.96

A novel pathway of antigen presentation by dendritic and endothelial cells: Implications for allorecognition and infectious diseases. Transplantation (2006) 0.96

Regulatory T-cell therapy in the induction of transplant tolerance: the issue of subpopulations. Transplantation (2014) 0.94

Indefinite mouse heart allograft survival in recipient treated with CD4(+)CD25(+) regulatory T cells with indirect allospecificity and short term immunosuppression. Transpl Immunol (2009) 0.94

Heterogeneous pattern of retinal nerve fiber layer in multiple sclerosis. High resolution optical coherence tomography: potential and limitations. PLoS One (2010) 0.94

Monitoring of in vivo function of superparamagnetic iron oxide labelled murine dendritic cells during anti-tumour vaccination. PLoS One (2011) 0.94

3-hydroxykynurenine suppresses CD4+ T-cell proliferation, induces T-regulatory-cell development, and prolongs corneal allograft survival. Invest Ophthalmol Vis Sci (2011) 0.93

Adoptive regulatory T cell therapy: challenges in clinical transplantation. Curr Opin Organ Transplant (2010) 0.93

Arginine depletion as a mechanism for the immune privilege of corneal allografts. Eur J Immunol (2011) 0.93

Generation and expansion of human CD4+ CD25+ regulatory T cells with indirect allospecificity: Potential reagents to promote donor-specific transplantation tolerance. Transplantation (2006) 0.93

Dendritic cells from CML patients have altered actin organization, reduced antigen processing, and impaired migration. Blood (2002) 0.93

Gene delivery by dendrimers operates via different pathways in different cells, but is enhanced by the presence of caveolin. J Immunol Methods (2006) 0.93

MicroRNAs affect dendritic cell function and phenotype. Immunology (2015) 0.92

A CIITA-independent pathway that promotes expression of endogenous rather than exogenous peptides in immune-privileged sites. Eur J Immunol (2004) 0.92

Effect of administration of CTLA4-Ig as protein or cDNA on corneal allograft survival. Invest Ophthalmol Vis Sci (2002) 0.92

Imbalance of effector and regulatory CD4 T cells is associated with graft-versus-host disease after hematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumab. Haematologica (2009) 0.92